Trading Members of the Exchange are hereby informed that effective from Thursday, September 21, 2017, the equity shares of Lasa Supergenerics Limited shall be listed and admitted to dealings on the Exchange in the list of T Group of Securities.
Further, trading in the scrip shall continue to remain in Trade-for-Trade segment till further notice since minimum of 100% of the promoter shareholding of the company is not in demat form, as per extant SEBI guidelines.
Members are requested to note that the above security will be a part of special pre-open session for IPO and Other category of scrip’s as per SEBI circular no. CIR/MRD/DP/01/2012 & CIR/MRD/DP/02/2012 dated January 20, 2012.
For further information on SPOS, the trading members are requested to refer to the Exchange’s notice no. 20120216-29 on Enabling Special Pre-open Session for IPO’s & Relisted Scrips. For any clarification on SPOS, the trading members may please contact the Helpdesk on 022-6136 3100 / 6136 3171.
|
Name of the Company
|
:
|
|
|
Registered Office
|
:
:
::
|
C-105, MIDC, Mahad, Raigad-402 301.
Tel: 02145-232101, 232202
Email Id: cs@lasalabs.com
Website: www.lasalabs.com
|
|
Company Secretary & Compliance Officer
|
:
:
|
Mr. Hitesh Dhruvkumar Wadhwani
Tel: +91-22 49701092
Email ID: cs@lasalabs.com
|
|
Securities
|
:
|
2,28,64,449 Equity shares of Rs. 10/- allotted pursuant to Composite Scheme of Arrangement
|
|
Distinctive numbers
|
:
|
01 to 2,28,64,449
|
|
Scrip Code
|
:
|
540702
|
|
Group
|
:
|
T
|
|
Market Lot
|
:
|
1
|
|
Face Value & Paid up value
|
:
|
Rs.10/- each fully paid
|
|
Scrip ID on BOLT System
|
:
|
LASA
|
|
Abbreviated name on BOLT
|
:
|
LASA
|
|
ISIN No.
|
:
|
INE670X01014
|
|
Lock in
|
:
|
Quantity
|
Dist. Nos.
|
Lock in Upto
|
|
|
|
22,86,445
|
1 to 2286445
|
30.09.2020
|
1. The brief particulars of the Composite Scheme of Arrangement are as mentioned below:
a) The Composite Scheme of Arrangement of the Company was approved by the Hon’ble
National Company Law Tribunal, Mumbai Bench vide its Order dated 13.04.2017
b) Appointed Date: 02.04.2015
c) Effective date: 02.05.2017
d) Date of Allotment: 14.06.2017
e) As per Composite Scheme of Arrangement sanctioned by the Hon’ble National Company Law
Tribunal, Mumbai Bench, between, Omkar Speciality Chemicals Ltd and Lasa Laboratory Private
Limited and Urdhwa Chemicals Company Private Limited and Rishichem Research Limited and
Desh Chemicals Private Limited and Lasa Supergenerics Limited and their respective
Shareholders and Creditors, the Veterinary API Undertaking of Omkar Speciality Chemicals
Limited (OSCL) has been transferred to and vested into Lasa Supergenerics Limited (LSL) and
in consideration thereof, LSL has issued and allotted to the shareholders of OSCL, Equity shares
of Rs.10/- each of LSL in the ratio of 1 (one) equity share of Rs.10/-
each fully paid up of LSL for every 1 (one) equity share of Rs.10/- each held in OSCL.
The issued, subscribed and paid-up equity capital of LSL post arrangement is Rs.
22,86,44,490/- Equity shares of Rs.10/- consisting of 2,28,64,449 Equity shares Rs.10/- each.
2. As per Exchange Notice No. 20170607-17 dated 07.06.2017, OSCL had fixed Record date
as 13.06.2017 for giving effect to the Scheme of Arrangement.
3. The Information Memorandum containing all the information about the company can be
viewed at http://www.bseindia.com/corporates/soa.aspx?expandable=3
4. The name and address of the registrar and share transfer agent of the company is as
mentioned below:
BIGSHARE SERVICES PRIVATE LIMITED
Bharat Tin Works Building , 1st Floor,
Makwana Road, Marol, Andheri (East)
Mumbai - 400 059
5. The shareholding pattern of the company post scheme of arrangement is enclosed as Annexure I.
Nitin Pujari
Sr. Manager
|